CNSP
NASDAQ · Pharmaceuticals
Cns Pharmaceuticals Inc
$5.33
+0.10 (+1.81%)
Open$5.21
Previous Close$5.24
Day High$5.36
Day Low$5.19
52W High$10.59
52W Low$1.90
Volume—
Avg Volume4.9K
Market Cap7.86M
P/E Ratio—
EPS$-29.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+700.4% upside
Current
$5.33
$5.33
Target
$42.66
$42.66
$27.73
$42.66 avg
$55.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 401.0K | 379.4K | 323.5K |
| Net Income | 137.9K | 129.6K | 106.9K |
| Profit Margin | 34.4% | 34.2% | 33.1% |
| EBITDA | 186.8K | 161.4K | 136.4K |
| Free Cash Flow | 134.0K | 130.1K | 98.1K |
| Rev Growth | +21.3% | -7.8% | +5.5% |
| Debt/Equity | 0.24 | 0.32 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |